Guardant Health (GH) EBIAT (2017 - 2025)
Historic EBIAT for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$92.7 million.
- Guardant Health's EBIAT rose 1394.75% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 2217.38%. This contributed to the annual value of -$436.4 million for FY2024, which is 898.45% up from last year.
- Latest data reveals that Guardant Health reported EBIAT of -$92.7 million as of Q3 2025, which was up 1394.75% from -$99.9 million recorded in Q2 2025.
- In the past 5 years, Guardant Health's EBIAT registered a high of -$72.3 million during Q4 2021, and its lowest value of -$229.4 million during Q2 2022.
- In the last 5 years, Guardant Health's EBIAT had a median value of -$107.5 million in 2021 and averaged -$118.1 million.
- Per our database at Business Quant, Guardant Health's EBIAT plummeted by 23729.62% in 2021 and then soared by 6828.21% in 2023.
- Over the past 5 years, Guardant Health's EBIAT (Quarter) stood at -$72.3 million in 2021, then plummeted by 93.52% to -$139.9 million in 2022, then plummeted by 33.67% to -$187.0 million in 2023, then skyrocketed by 40.65% to -$111.0 million in 2024, then increased by 16.47% to -$92.7 million in 2025.
- Its EBIAT was -$92.7 million in Q3 2025, compared to -$99.9 million in Q2 2025 and -$95.2 million in Q1 2025.